Today Nycomed Amersham Imaging announced its acquisition of the Bruker Tomojet power injector system from Swiss firm Bruker. Tomojet is a pump injector for the administration of contrast media for diagnostic investigations, and is available in versions suitable for both MR and CT applications, according to Nycomed Amersham of Buckinghamshire, U.K.
Typical applications for Tomojet include: contrast angiography, tumor diagnostics, organ perfusion, and incremental body imaging, according to Nycomed Amersham. Tomojet is currently being marketed in Europe and other international markets, and will continue to be manufactured by Bruker in Zurich, Switzerland.
By AuntMinnie.com staff writersJanuary 24, 2001
Related Reading
E-Z-EM inks European deal with Nycomed-Amersham, December 18, 2000
Copyright © 2001 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
